Dr Reddy s initiates process for emergency use authorisation of Sputnik V-ANI

Hyderabad (Telangana) [India], Feb 19 (ANI): Dr Reddy's Laboratories said on Friday it has initiated the process with the Drugs Controller General of India (DCGI) for emergency use authorisation of human adenoviral vector-based platform vaccine candidate Sputnik V.
As part of the review process, Dr Reddy's will present the safety profile of phase two study and interim data of phase three study which is expected to complete by February 21.
"The efficacy of Sputnik V was reported to be 91.6 per cent by the Lancet, which is an impressive development in the fight against Covid-19," said Co-chairman and Managing Director G V Prasad.

Related Keywords

India ,Russia ,Russian , ,Gamaleya National Research Institute Of Epidemiology ,Ministry Of Health Russia On ,Russian Direct Investment Fund ,Drugs Controller General ,Gamaleya National Research Institute ,Dr Reddy 39s Laboratories ,Co Chairman And Managing Directorgv Prasad ,Sputnik V ,Drugs Controller General Of India Dcgi ,Emergency Use Authorisation ,Russian Direct Investment Fund Rdif ,Adenoviral Vaccines ,இந்தியா ,ரஷ்யா ,ரஷ்ய ,அமைச்சகம் ஆஃப் ஆரோக்கியம் ரஷ்யா ஆன் ,ரஷ்ய நேரடி முதலீடு நிதி ,மருந்துகள் கட்டுப்படுத்தி ஜநரல் ,ஸ்பட்நிக் வ் ,